TPST Tempest Therapeutics Inc : Bullish and Bearish Analyst Opinions
Sentiment & Price
▼
Sentiment Gauge
1
Bull
0
Bear
0
Watch
Bull 100%
Bear 0%
Price & Sentiment
Loading chart...
Recent News
Top Views ▼
No recent news for TPST
No theses available
Feed
20:29
Apr 17
Apr 17
Tempest AI has strong growth potential.
Initiated a position in Tempest AI, a precision medicine biotech company leveraging AI in healthcare, due to its large clinical database, revenue guidance of $1.6 billion for 2026, and a contract with Gilead, offering high reward for the risk.
HIGH
About TPST Analyst Coverage
Buzzberg tracks TPST (Tempest Therapeutics Inc) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked.